Form D — Embold Therapeutics, Inc.
0002109643-26-000003 · filed Jul 24, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $4,975,000
- Total sold
- $2,470,587
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Embold Therapeutics, Inc.
- CIK
- 2109643
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 2682 EATON AVE
REDWOOD CITY, CA 94062 - Phone
- (650) 200-7297
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Gjalt W. Huisman · Executive OfficerRedwood City, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗